Theriva™ biologics and sant joan de dÉu-barcelona children's hospital advance strategic collaboration to explore the combination of vcn-01 with topoisomerase inhibitors to treat cancer

- theriva signs exclusive option to license intellectual property from sant joan de dÉu-barcelona children's hospital (sjd) to explore the therapeutic potential of vcn-01 in combination with topoisomerase i inhibitors -
TOVX Ratings Summary
TOVX Quant Ranking